BACKGROUND: Although autoantibodies to cancer antigens are candidates for biomarkers, no comprehensive studies to detect cancer-specific antibodies have been performed. This study identified autoantibodies in the sera of pancreatic cancer (PC) patients using proteomics based on a wheat germ cell-free protein production system. METHODS: We constructed a biotinylated protein library of 2,183 genes. Interactions between biotinylated proteins and serum antibodies were detected by AlphaScreen® assay. Relative luminescence signals of each protein in 37 PC patients and 20 healthy controls were measured, and their sensitivity and specificity for PC were calculated. RESULTS: Luminescence signals of nine proteins were significantly higher than those of healthy controls, with calcium and integrin binding 1 (CIB1) protein showing the greatest significance (p = 0.002). Sensitivity, specificity, positive predictive value and negative predictive value of CIB1 autoantibody alone for PC were 76, 70, 82, and 61 %, respectively, and 97, 35, 74, and 88 %, respectively, when the four most significant proteins were combined. Presence of these autoantibodies did not vary significantly with other clinicopathological characteristics. CONCLUSION: Several autoantibodies, including CIB1, are potential biomarkers for PC.
RCT Entities:
BACKGROUND: Although autoantibodies to cancer antigens are candidates for biomarkers, no comprehensive studies to detect cancer-specific antibodies have been performed. This study identified autoantibodies in the sera of pancreatic cancer (PC) patients using proteomics based on a wheat germ cell-free protein production system. METHODS: We constructed a biotinylated protein library of 2,183 genes. Interactions between biotinylated proteins and serum antibodies were detected by AlphaScreen® assay. Relative luminescence signals of each protein in 37 PC patients and 20 healthy controls were measured, and their sensitivity and specificity for PC were calculated. RESULTS: Luminescence signals of nine proteins were significantly higher than those of healthy controls, with calcium and integrin binding 1 (CIB1) protein showing the greatest significance (p = 0.002). Sensitivity, specificity, positive predictive value and negative predictive value of CIB1 autoantibody alone for PC were 76, 70, 82, and 61 %, respectively, and 97, 35, 74, and 88 %, respectively, when the four most significant proteins were combined. Presence of these autoantibodies did not vary significantly with other clinicopathological characteristics. CONCLUSION: Several autoantibodies, including CIB1, are potential biomarkers for PC.
Authors: Michela Capello; Leonidas E Bantis; Ghislaine Scelo; Yang Zhao; Peng Li; Dilsher S Dhillon; Nikul J Patel; Deepali L Kundnani; Hong Wang; James L Abbruzzese; Anirban Maitra; Margaret A Tempero; Randall Brand; Matthew A Firpo; Sean J Mulvihill; Matthew H Katz; Paul Brennan; Ziding Feng; Ayumu Taguchi; Samir M Hanash Journal: J Natl Cancer Inst Date: 2017-04-01 Impact factor: 13.506
Authors: Emma Sierecki; Loes M Stevers; Nichole Giles; Mark E Polinkovsky; Mehdi Moustaqil; Sergey Mureev; Wayne A Johnston; Mareike Dahmer-Heath; Dubravka Skalamera; Thomas J Gonda; Brian Gabrielli; Brett M Collins; Kirill Alexandrov; Yann Gambin Journal: Mol Cell Proteomics Date: 2014-05-27 Impact factor: 5.911
Authors: Sarah Spear; Juliana B Candido; Jacqueline R McDermott; Cristina Ghirelli; Eleni Maniati; Stephen A Beers; Frances R Balkwill; Hemant M Kocher; Melania Capasso Journal: Front Immunol Date: 2019-03-27 Impact factor: 7.561
Authors: Sven Jacob; Florian Bösch; Markus B Schoenberg; Elise Pretzsch; Christopher Lampert; Ren Haoyu; Bernhard W Renz; Marlies Michl; Jörg Kumbrink; Thomas Kirchner; Jens Werner; Martin K Angele; Jens Neumann Journal: BMC Cancer Date: 2021-11-18 Impact factor: 4.430
Authors: W Zhu; B L Gliddon; K E Jarman; P A B Moretti; T Tin; L V Parise; J M Woodcock; J A Powell; A Ruszkiewicz; M R Pitman; S M Pitson Journal: Oncogene Date: 2016-12-12 Impact factor: 9.867